Terms: = Brain cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Prognosis
9 results:
1. Transcription factor Nrf2 binds to circRNAPIBF1 to regulate SOD2 in lung adenocarcinoma progression.
Zhang Z; Chen Q; Huang C; Rao D; Sang C; Zhu S; Gu L; Xie C; Tang Z; Xu X
Mol Carcinog; 2022 Dec; 61(12):1161-1176. PubMed ID: 36193777
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical features and prognosis of patients with leptomeningeal metastases].
Zhang ML; Ma WF; Gao XY; Shi YY; Liu HQ; Jiang YS; Qin LZ; Yuan LP; Li W; Zhang JW
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(16):1154-1159. PubMed ID: 33902246
[No Abstract] [Full Text] [Related]
3. High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.
Ferris SP; Velazquez Vega J; Aboian M; Lee JC; Van Ziffle J; Onodera C; Grenert JP; Saunders T; Chen YY; Banerjee A; Kline CN; Gupta N; Raffel C; Samuel D; Ruiz-Diaz I; Magaki S; Wilson D; Neltner J; Al-Hajri Z; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Schniederjan M; Cha S; Perry A; Solomon DA
Brain Pathol; 2020 Jan; 30(1):46-62. PubMed ID: 31104347
[TBL] [Abstract] [Full Text] [Related]
4. Bradykinin B1 receptor contributes to interleukin-8 production and glioblastoma migration through interaction of STAT3 and SP-1.
Liu YS; Hsu JW; Lin HY; Lai SW; Huang BR; Tsai CF; Lu DY
Neuropharmacology; 2019 Jan; 144():143-154. PubMed ID: 30366000
[TBL] [Abstract] [Full Text] [Related]
5. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
[TBL] [Abstract] [Full Text] [Related]
6. Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.
Yin S; Kaluz S; Devi NS; Jabbar AA; de Noronha RG; Mun J; Zhang Z; Boreddy PR; Wang W; Wang Z; Abbruscato T; Chen Z; Olson JJ; Zhang R; Goodman MM; Nicolaou KC; Van Meir EG
Clin Cancer Res; 2012 Dec; 18(24):6623-33. PubMed ID: 22923450
[TBL] [Abstract] [Full Text] [Related]
7. Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.
Zhao Z; Liu Y; He H; Chen X; Chen J; Lu YC
Brain Res Bull; 2011 Oct; 86(3-4):189-94. PubMed ID: 21807073
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of E1A double mutant oncolytic adenovectors in anti-glioma gene therapy.
Ulasov IV; Tyler MA; Rivera AA; Nettlebeck DM; Douglas JT; Lesniak MS
J Med Virol; 2008 Sep; 80(9):1595-603. PubMed ID: 18649343
[TBL] [Abstract] [Full Text] [Related]
9. Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q.
Tews B; Roerig P; Hartmann C; Hahn M; Felsberg J; Blaschke B; Sabel M; Kunitz A; Toedt G; Neben K; Benner A; von Deimling A; Reifenberger G; Lichter P
Oncogene; 2007 Jul; 26(34):5010-6. PubMed ID: 17311001
[TBL] [Abstract] [Full Text] [Related]
